News
(NASDAQ:ARVN), who have seen the share price tank a massive 86% over a three year period. That might cause some serious doubts about the merits of the initial decision to buy the stock, to put it ...
19h
Zacks Investment Research on MSNAmarin's Q2 Earnings & Revenues Trump Estimates, Stock RisesAmarin Corporation AMRN reported a loss of 3 cents per share for the second quarter of 2025, which was significantly narrower ...
19h
Zacks Investment Research on MSNUTHR Q2 Earnings Miss Estimates, Higher Tyvaso Sales Aid Revenues Y/YUnited Therapeutics UTHR reported second-quarter 2025 earnings of $6.41 per share, which missed the Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results